155 related articles for article (PubMed ID: 36099835)
1. Detection of prostate cancer biomarkers via a SERS-based aptasensor.
Zhao J; Wang J; Liu Y; Han XX; Xu B; Ozaki Y; Zhao B
Biosens Bioelectron; 2022 Nov; 216():114660. PubMed ID: 36099835
[TBL] [Abstract][Full Text] [Related]
2. A novel label-free colorimetric aptasensor for sensitive determination of PSA biomarker using gold nanoparticles and a cationic polymer in human serum.
Shayesteh OH; Ghavami R
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 226():117644. PubMed ID: 31614271
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive SERS aptasensor using Au@Ag bimetallic nanorod SERS tags for the selective detection of amantadine in foods.
Wang X; Chen C; Waterhouse GIN; Qiao X; Sun Y; Xu Z
Food Chem; 2024 Sep; 453():139665. PubMed ID: 38776796
[TBL] [Abstract][Full Text] [Related]
4. A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer.
Hassani S; Salek Maghsoudi A; Rezaei Akmal M; Rahmani SR; Sarihi P; Ganjali MR; Norouzi P; Abdollahi M
J Pharm Pharm Sci; 2020; 23():243-258. PubMed ID: 32649855
[TBL] [Abstract][Full Text] [Related]
5. Surface-enhanced Raman spectroscopy aptasensor for simultaneous determination of ochratoxin A and zearalenone using Au@Ag core-shell nanoparticles and gold nanorods.
Chen R; Li S; Sun Y; Huo B; Xia Y; Qin Y; Li S; Shi B; He D; Liang J; Gao Z
Mikrochim Acta; 2021 Jul; 188(8):281. PubMed ID: 34331147
[TBL] [Abstract][Full Text] [Related]
6. A target-triggered and self-calibration aptasensor based on SERS for precise detection of a prostate cancer biomarker in human blood.
Wu Q; Chen G; Qiu S; Feng S; Lin D
Nanoscale; 2021 Apr; 13(16):7574-7582. PubMed ID: 33928988
[TBL] [Abstract][Full Text] [Related]
7. A SERS-LFA biosensor combined with aptamer recognition for simultaneous detection of thrombin and PDGF-BB in prostate cancer plasma.
Cao X; Song Q; Sun Y; Mao Y; Lu W; Li L
Nanotechnology; 2021 Aug; 32(44):. PubMed ID: 34298537
[TBL] [Abstract][Full Text] [Related]
8. Low background interference SERS aptasensor for highly sensitive multiplex mycotoxin detection based on polystyrene microspheres-mediated controlled release of Raman reporters.
Yang Y; Su Z; Wu D; Liu J; Zhang X; Wu Y; Li G
Anal Chim Acta; 2022 Jul; 1218():340000. PubMed ID: 35701039
[TBL] [Abstract][Full Text] [Related]
9. Electrochemical bioassay development for ultrasensitive aptasensing of prostate specific antigen.
Heydari-Bafrooei E; Shamszadeh NS
Biosens Bioelectron; 2017 May; 91():284-292. PubMed ID: 28033557
[TBL] [Abstract][Full Text] [Related]
10. A novel SERS-based magnetic aptasensor for prostate specific antigen assay with high sensitivity.
Yang K; Hu Y; Dong N; Zhu G; Zhu T; Jiang N
Biosens Bioelectron; 2017 Aug; 94():286-291. PubMed ID: 28292735
[TBL] [Abstract][Full Text] [Related]
11. Target-activatable gold nanoparticle-based aptasensing for protein biomarkers using stimuli-responsive aggregation.
Liu G; Feng DQ; Li Z; Feng Y
Talanta; 2019 Jan; 192():112-117. PubMed ID: 30348365
[TBL] [Abstract][Full Text] [Related]
12. Construction of a sensitive and selective plasmonic biosensor for prostate specific antigen by combining magnetic molecularly-imprinted polymer and surface-enhanced Raman spectroscopy.
Turan E; Zengin A; Suludere Z; Kalkan NÖ; Tamer U
Talanta; 2022 Jan; 237():122926. PubMed ID: 34736663
[TBL] [Abstract][Full Text] [Related]
13. Rapid aptasensor capable of simply diagnosing prostate cancer.
Cha T; Cho S; Kim YT; Lee JH
Biosens Bioelectron; 2014 Dec; 62():31-7. PubMed ID: 24973540
[TBL] [Abstract][Full Text] [Related]
14. Vertical flow assays based on core-shell SERS nanotags for multiplex prostate cancer biomarker detection.
Chen R; Liu B; Ni H; Chang N; Luan C; Ge Q; Dong J; Zhao X
Analyst; 2019 Jul; 144(13):4051-4059. PubMed ID: 31157328
[TBL] [Abstract][Full Text] [Related]
15. Aptamer-Based Functionalized SERS Biosensor for Rapid and Ultrasensitive Detection of Gastric Cancer-Related Biomarkers.
Shao P; Dong D; Huang Y; Wang Y; Pan L; Zhu Q; Wu Z; Jiang F; Wei W
Int J Nanomedicine; 2023; 18():7523-7532. PubMed ID: 38106450
[TBL] [Abstract][Full Text] [Related]
16. Hybridization induced fluorescence enhanced DNA-Ag nanocluster/aptamer probe for detection of prostate-specific antigen.
Fang BY; An J; Liu B; Zhao YD
Colloids Surf B Biointerfaces; 2019 Mar; 175():358-364. PubMed ID: 30554014
[TBL] [Abstract][Full Text] [Related]
17. Development of Fe
Chen R; Sun Y; Huo B; Mao Z; Wang X; Li S; Lu R; Li S; Liang J; Gao Z
Anal Chim Acta; 2021 Oct; 1180():338888. PubMed ID: 34538331
[TBL] [Abstract][Full Text] [Related]
18. Classification analyses for prostate cancer, benign prostate hyperplasia and healthy subjects by SERS-based immunoassay of multiple tumour markers.
Zhou L; Liu Y; Wang F; Jia Z; Zhou J; Jiang T; Petti L; Chen Y; Xiong Q; Wang X
Talanta; 2018 Oct; 188():238-244. PubMed ID: 30029370
[TBL] [Abstract][Full Text] [Related]
19. Detection of prostate specific antigen in whole blood by microfluidic chip integrated with dielectrophoretic separation and electrochemical sensing.
Wang X; He X; He Z; Hou L; Ge C; Wang L; Li S; Xu Y
Biosens Bioelectron; 2022 May; 204():114057. PubMed ID: 35168025
[TBL] [Abstract][Full Text] [Related]
20. An ultrasensitive and dual-recognition SERS biosensor based on Fe
Qi X; Ye Y; Wang H; Zhao B; Xu L; Zhang Y; Wang X; Zhou N
Talanta; 2022 Dec; 250():123648. PubMed ID: 35870283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
